首页> 美国卫生研究院文献>Cancer Biology Therapy >Overexpression of the pp32r1 (ANP32C) oncogene or its functional mutant pp32r1Y140H confers enhanced resistance to FTY720 (Finguimod)
【2h】

Overexpression of the pp32r1 (ANP32C) oncogene or its functional mutant pp32r1Y140H confers enhanced resistance to FTY720 (Finguimod)

机译:pp32r1(ANP32C)癌基因或其功能突变体pp32r1Y140H的过表达赋予对FTY720(Finguimod)的增强抗性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

pp32r1 (ANP32C) is oncogenic and has been shown to be overexpressed in tumors of the breast, prostate, and pancreas. In this work we show that pp32 family proteins are able to bind to the sphingosine analog FTY720 (Finguimod). Molecular docking studies highlight that a conserved residue F136 is likely to be a key determinant of the FTY720 binding site on the pp32 leucine-rich repeat domain. Transduction of the renal carcinoma cell line ACHN or cervical cancer cell line HeLa with lentivirus expressing the oncogenic family member pp32r1 or a pp32r1Y140H functional mutant illustrated an enhanced resistance to FTY720 induced apoptosis. These findings highlight that certain cancers overexpressing pp32r1 or pp32r1 mutants are likely to demonstrate enhanced resistance to FTY720 treatment.
机译:pp32r1(ANP32C)具有致癌性,并且已显示在乳腺癌,前列腺癌和胰腺癌中过表达。在这项工作中,我们表明pp32家族蛋白能够与鞘氨醇类似物FTY720(Finguimod)结合。分子对接研究强调,保守残基F136可能是pp32富含亮氨酸的重复域上FTY720结合位点的关键决定因素。表达致癌家族成员pp32r1或pp32r1Y140H功能突变体的慢病毒对肾癌细胞系ACHN或宫颈癌细胞系HeLa的转导显示出对FTY720诱导的凋亡的增强抵抗力。这些发现表明,某些过度表达pp32r1或pp32r1突变体的癌症可能表现出对FTY720治疗的抗性增强。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号